drugset / Trial / NCT00362609

Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD

NCT00362609

Phase 3 Completed 59 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether or not consistent drug levels can be achieved in infants with presumed Gastroesophageal Reflux Disease.

Timeline

Start
2006-07
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pantoprazole Other / unclassified